Our prior studies demonstrated that silencing of PTEN expression increased the transcription and secretion of CXCL8 and increased gene expression of the receptors CXCR1 and CXCR2 in prostate cancer cells [20]. The gene discussed is CXCR1; the disease is prostate carcinoma.